Results for tag: "Cinqair"

Cinqair is a type of asthma drug used to treat severe asthma. It is a monoclonal antibody that works by blocking the action of interleukin-5, a protein that plays a role in the inflammation associated with asthma. Cinqair is administered as an intravenous infusion and is typically used in combination with other asthma medications. It is approved for use in adults and adolescents aged 12 years and older. Cinqair is a relatively new drug, having been approved by the US Food and Drug Administration in 2015. It is currently marketed by Teva Pharmaceuticals in the United States and by Novartis in Europe. Other companies involved in the Cinqair market include GlaxoSmithKline, Merck, and AstraZeneca. Show Less Read more